instruction
stringlengths 30
82
| output
stringlengths 13
790
|
|---|---|
How long is the variation length for RS587778856 SNP?
|
The variation length is 1 base pairs.
|
What is the origin for RS587778856 SNP?
|
The origin is somatic.
|
What is the type of genetic variation for RS587778856 SNP?
|
The variation is a single nucleotide variant.
|
What is the genetic molecular consequence for RS587778856 SNP?
|
The resulting gene consequence is a synonymous variant.
|
Which condition is asociated with RS587778845 SNP?
|
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS587778845 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS587778845 SNP.
|
In which chromosome is RS587778845 SNP located?
|
It is located in the chromosome 13.
|
Which methods support the evidence found for the RS587778845 SNP?
|
Associated methods are: research.
|
What is the clinical significance of RS587778845 SNP, is it benign or pathogenic?
|
It is Pathogenic.
|
How long is the variation length for RS587778845 SNP?
|
The variation length is 1 base pairs.
|
What is the origin for RS587778845 SNP?
|
The origin is somatic.
|
What is the type of genetic variation for RS587778845 SNP?
|
The variation is a single nucleotide variant.
|
What is the genetic molecular consequence for RS587778845 SNP?
|
The resulting gene consequence is a nonsense.
|
Which condition is asociated with RS587778847 SNP?
|
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS587778847 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS587778847 SNP.
|
In which chromosome is RS587778847 SNP located?
|
It is located in the chromosome 13.
|
Which methods support the evidence found for the RS587778847 SNP?
|
Associated methods are: research.
|
What is the clinical significance of RS587778847 SNP, is it benign or pathogenic?
|
It is Pathogenic.
|
How long is the variation length for RS587778847 SNP?
|
The variation length is 1 base pairs.
|
What is the origin for RS587778847 SNP?
|
The origin is somatic.
|
What is the type of genetic variation for RS587778847 SNP?
|
The variation is a single nucleotide variant.
|
What is the genetic molecular consequence for RS587778847 SNP?
|
The resulting gene consequence is a missense variant.
|
Which condition is asociated with RS587778863 SNP?
|
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS587778863 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS587778863 SNP.
|
In which chromosome is RS587778863 SNP located?
|
It is located in the chromosome 13.
|
Which methods support the evidence found for the RS587778863 SNP?
|
Associated methods are: research.
|
What is the clinical significance of RS587778863 SNP, is it benign or pathogenic?
|
It is Pathogenic.
|
How long is the variation length for RS587778863 SNP?
|
The variation length is 1 base pairs.
|
What is the origin for RS587778863 SNP?
|
The origin is somatic.
|
What is the type of genetic variation for RS587778863 SNP?
|
The variation is a single nucleotide variant.
|
What is the genetic molecular consequence for RS587778863 SNP?
|
The resulting gene consequence is a nonsense.
|
Which condition is asociated with RS587781256 SNP?
|
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS587781256 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS587781256 SNP.
|
In which chromosome is RS587781256 SNP located?
|
It is located in the chromosome 13.
|
Which methods support the evidence found for the RS587781256 SNP?
|
Associated methods are: clinical testing.
|
What is the clinical significance of RS587781256 SNP, is it benign or pathogenic?
|
It is Pathogenic.
|
How long is the variation length for RS587781256 SNP?
|
The variation length is 21 base pairs.
|
What is the origin for RS587781256 SNP?
|
The origin is germline.
|
What is the type of genetic variation for RS587781256 SNP?
|
The variation is a Deletion.
|
What is the genetic molecular consequence for RS587781256 SNP?
|
The resulting gene consequence is a intron variant.
|
Which condition is asociated with RS587781257 SNP?
|
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS587781257 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS587781257 SNP.
|
In which chromosome is RS587781257 SNP located?
|
It is located in the chromosome 13.
|
Which methods support the evidence found for the RS587781257 SNP?
|
Associated methods are: clinical testing.
|
What is the clinical significance of RS587781257 SNP, is it benign or pathogenic?
|
It is Pathogenic.
|
How long is the variation length for RS587781257 SNP?
|
The variation length is 1 base pairs.
|
What is the origin for RS587781257 SNP?
|
The origin is germline.
|
What is the type of genetic variation for RS587781257 SNP?
|
The variation is a Deletion.
|
What is the genetic molecular consequence for RS587781257 SNP?
|
The resulting gene consequence is a frameshift variant.
|
Which condition is asociated with DEL399102?
|
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsDEL399102. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/DEL399102.
|
In which chromosome is DEL399102 located?
|
It is located in the chromosome 13.
|
Which methods support the evidence found for the DEL399102?
|
Associated methods are: clinical testing.
|
What is the clinical significance of DEL399102, is it benign or pathogenic?
|
It is Pathogenic.
|
How long is the variation length for DEL399102?
|
The variation length is 2601 base pairs.
|
What is the origin for DEL399102?
|
The origin is germline.
|
What is the type of genetic variation for DEL399102?
|
The variation is a Deletion.
|
Which condition is asociated with DEL399611?
|
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsDEL399611. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/DEL399611.
|
In which chromosome is DEL399611 located?
|
It is located in the chromosome 13.
|
Which methods support the evidence found for the DEL399611?
|
Associated methods are: clinical testing.
|
What is the clinical significance of DEL399611, is it benign or pathogenic?
|
It is Likely pathogenic.
|
How long is the variation length for DEL399611?
|
The variation length is 1850 base pairs.
|
What is the origin for DEL399611?
|
The origin is germline.
|
What is the type of genetic variation for DEL399611?
|
The variation is a Deletion.
|
Which condition is asociated with DEL463437?
|
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsDEL463437. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/DEL463437.
|
In which chromosome is DEL463437 located?
|
It is located in the chromosome 13.
|
Which methods support the evidence found for the DEL463437?
|
Associated methods are: clinical testing.
|
What is the clinical significance of DEL463437, is it benign or pathogenic?
|
It is Pathogenic.
|
How long is the variation length for DEL463437?
|
The variation length is 41756 base pairs.
|
What is the origin for DEL463437?
|
The origin is germline.
|
What is the type of genetic variation for DEL463437?
|
The variation is a Deletion.
|
Which condition is asociated with RS1555282775 SNP?
|
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1555282775 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1555282775 SNP.
|
In which chromosome is RS1555282775 SNP located?
|
It is located in the chromosome 13.
|
Which methods support the evidence found for the RS1555282775 SNP?
|
Associated methods are: clinical testing.
|
What is the clinical significance of RS1555282775 SNP, is it benign or pathogenic?
|
It is Pathogenic.
|
How long is the variation length for RS1555282775 SNP?
|
The variation length is 1 base pairs.
|
What is the origin for RS1555282775 SNP?
|
The origin is germline.
|
What is the type of genetic variation for RS1555282775 SNP?
|
The variation is a single nucleotide variant.
|
What is the genetic molecular consequence for RS1555282775 SNP?
|
The resulting gene consequence is a nonsense.
|
Which condition is asociated with RS1555294600 SNP?
|
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1555294600 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1555294600 SNP.
|
In which chromosome is RS1555294600 SNP located?
|
It is located in the chromosome 13.
|
Which methods support the evidence found for the RS1555294600 SNP?
|
Associated methods are: clinical testing.
|
What is the clinical significance of RS1555294600 SNP, is it benign or pathogenic?
|
It is Pathogenic.
|
How long is the variation length for RS1555294600 SNP?
|
The variation length is 2 base pairs.
|
What is the origin for RS1555294600 SNP?
|
The origin is germline.
|
What is the type of genetic variation for RS1555294600 SNP?
|
The variation is a Insertion.
|
What is the genetic molecular consequence for RS1555294600 SNP?
|
The resulting gene consequence is a frameshift variant.
|
Which condition is asociated with DEL527719?
|
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsDEL527719. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/DEL527719.
|
In which chromosome is DEL527719 located?
|
It is located in the chromosome 13.
|
Which methods support the evidence found for the DEL527719?
|
Associated methods are: clinical testing.
|
What is the clinical significance of DEL527719, is it benign or pathogenic?
|
It is Pathogenic.
|
How long is the variation length for DEL527719?
|
The variation length is 176171 base pairs.
|
What is the origin for DEL527719?
|
The origin is germline.
|
What is the type of genetic variation for DEL527719?
|
The variation is a Deletion.
|
Which condition is asociated with RS1566234123 SNP?
|
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1566234123 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1566234123 SNP.
|
In which chromosome is RS1566234123 SNP located?
|
It is located in the chromosome 13.
|
Which methods support the evidence found for the RS1566234123 SNP?
|
Associated methods are: clinical testing.
|
What is the clinical significance of RS1566234123 SNP, is it benign or pathogenic?
|
It is Pathogenic.
|
How long is the variation length for RS1566234123 SNP?
|
The variation length is 1 base pairs.
|
What is the origin for RS1566234123 SNP?
|
The origin is germline.
|
What is the type of genetic variation for RS1566234123 SNP?
|
The variation is a Duplication.
|
What is the genetic molecular consequence for RS1566234123 SNP?
|
The resulting gene consequence is a frameshift variant.
|
Which condition is asociated with RS1566199059 SNP?
|
Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1566199059 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1566199059 SNP.
|
In which chromosome is RS1566199059 SNP located?
|
It is located in the chromosome 13.
|
Which methods support the evidence found for the RS1566199059 SNP?
|
Associated methods are: clinical testing.
|
What is the clinical significance of RS1566199059 SNP, is it benign or pathogenic?
|
It is Pathogenic.
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.